{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-284671","form_type":"8-K","ticker":"JAZZ","cik":"0001232524","company_name":"Jazz Pharmaceuticals plc","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.889611+00:00","generated_at":"2026-06-21T19:34:54.581332+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Jazz completes ex-U.S. divestiture of Sunosi to Axsome","bullets":["Completed ex-U.S. divestiture of Sunosi (solriamfetol) to Axsome Therapeutics on November 14, 2022.","Earlier U.S. divestiture of Sunosi completed on May 9, 2022.","Original deal announced on March 28, 2022; global divestiture now fully completed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-284671","json":"https://secwatch.observer/filing/0001193125-22-284671.json","markdown":"https://secwatch.observer/filing/0001193125-22-284671.md","text":"https://secwatch.observer/filing/0001193125-22-284671.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1232524/000119312522284671/0001193125-22-284671-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1232524/000119312522284671/d394621d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T19:34:54.581332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}